PezoldAPlantGT. Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev. Epub ahead of print 12 January 2014. DOI: 10.1016/j.autrev.2014.01.009.
2.
TintoréMRoviraARioJ. Is optic neuritis more benign than other first attacks in multiple sclerosis?Ann Neurol2005;57: 210–215.
FazzoneHELeftonDRKupersmithMJ. Optic neuritis: Correlation of pain and magnetic resonance imaging. Ophthalmology2003; 110: 1646–1649.
6.
LeporeF. The origin of pain in optic neuritis. Arch Neurol1991; 48: 748-749.
7.
KeltnerJLJohnsonCASpurrJO. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol1999; 128: 543–553.
8.
SacksJGMelenO. Bitemporal visual field defects in presumed multiple sclerosis. JAMA1975; 234: 69–72.
9.
BeckRWGalRLBhattiMT. Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Am J Ophthalmol2004; 137: 77–83.
10.
Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up. Arch Neurol2008; 65: 727–732.
11.
SwantonJKRoviraATintoreM. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: A multicentre retrospective study. Lancet Neurol2007; 6: 677–686.
12.
RoviraASwantonJTintoreM. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol2009; 66: 587–592.
13.
KhannaSSharmaAHueckerJ. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol2012; 32: 216–220.
14.
StoroniMDavagnanamIRadonM. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: A novel magnetic resonance imaging scoring system. J Neuroophthalmol2013; 33: 123–127.
15.
SeongGMKimJHLimGC. Clinicopathological review of immunohistochemically defined Kikuchi–Fujimoto disease including some interesting cases. Clin Rheumatol2012; 31: 1463–1469.
16.
SantanaALessaBGalraoL. Kikuchi–Fujimoto’s disease associated with systemic lupus erythematosus: Case report and review of the literature. Clin Rheumatol2005; 24: 60–63.
17.
Hsiang-ChengCJenn-HuangLGuo-ShuH. Systemic lupus erythematosus with simultaneous onset of Kikuchi–Fujimoto’s disease complicated with antiphospholipid syndrome: A case report and review of the literature. Rheumatol Int2005; 25: 303–306.
18.
KojimaMMotooriTAsanoS. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract2007; 203: 423–431.
19.
KampylafkaEIAlexopoulosHKosmidisML. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: A 3-year prospective study of 370 patients. PLoS ONE2013; 8: e55843.
20.
SongJYLeeJParkDW. Clinical outcome and predictive factors of recurrence among patients with Kikuchi’s disease. Int J Infect Dis2009; 13: 322–326.
